文献速递产科母胎医学

结合母亲年龄与父母偏好的早孕期唐氏综合征产前筛查策略比较

A comparison of first trimester prenatal screening strategies for Down Syndrome with maternal age and preferences considerations.
PubMed 文献 · Prenat Diagn · 2020-08-31

本研究用决策树分析3855500例12至50岁孕妇,比较传统筛查、 contingent cfDNA与全员cfDNA筛查在不良结局数上的表现;全员cfDNA在各情景下不良结局最少,contingent cfDNA在识别高危行cfDNA的切点较低时优于传统筛查,切点随母亲年龄与父母偏好变化。

要点

  • 全员cfDNA筛查在所有情景下不良结局数最少。
  • contingent cfDNA在高危切点较低时优于传统筛查。
  • 选择contingent cfDNA切点时应考虑母亲年龄与父母偏好。

核心结论

  • 选择contingent cfDNA切点时应考虑母亲年龄与父母偏好,以使其相较传统筛查保持有效并提高患者满意度。

研究设计与样本

  • 决策树分析3855500例12至50岁孕妇队列,比较传统筛查、contingent cfDNA与全员cfDNA筛查策略在不同切点下的表现。

主要发现

  • 全员cfDNA筛查在每种情景下不良结局数最少。
  • contingent cfDNA在用于识别高危以行cfDNA检测的切点相对较低时,表现优于传统筛查。
  • 这些切点随母亲年龄与父母偏好而变化。

临床怎么用

  • 原文结论认为选择contingent cfDNA切点时应考虑母亲年龄与父母偏好,以保持其相较传统筛查的有效性并提高患者满意度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Screening for Down Syndrome (DS) includes traditional ultrasound and serum-based and cell-free DNA (cfDNA) testing. While cfDNA testing usually has superior performance, it is significantly more costly. As an alternative, a hybrid strategy combining contingent cfDNA with traditional testing is recommended when universal cfDNA screening is not feasible. This study compares the efficacy of traditional, contingent cfDNA, and universal cfDNA screening strategies at various cut-offs based on maternal age and parents' preferences, which may improve testing outcomes and patients' satisfaction. METHOD: Decision trees were used to analyze a cohort of 3 855 500 pregnancies from 12 to 50 years old. The performance of the strategies was compared using the number of adverse outcomes (undetected DS live births and euploid procedure-related losses). RESULTS: Universal cfDNA results in the fewest number of adverse outcomes in every scenario. Contingent cfDNA performs better than traditional screening when the cut-offs used to identify high-risk cases for cfDNA testing are relatively low. These cut-offs change depending on the maternal age and parents' preference. CONCLUSION: Maternal age and parents' preferences should be considered when choosing cut-offs for contingent cfDNA to remain as an effective strategy compared to traditional screening and to improve patient satisfaction.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Fujimoto AB, Ayer T, Caughey AB, et al. A comparison of first trimester prenatal screening strategies for Down Syndrome with maternal age and preferences considerations. Prenat Diagn. 2020. PMID: 32794316. doi:10.1002/pd.5811

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。